These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25222391)

  • 1. Generic statins: effectiveness, affordability, and patient adherence.
    Cullen W; Murray P; Harnett A
    Ann Intern Med; 2014 Sep; 161(6):447-8. PubMed ID: 25222391
    [No Abstract]   [Full Text] [Related]  

  • 2. Summaries for patients. Comparative effectiveness of generic and brand-name statins on patient outcomes.
    Ann Intern Med; 2014 Sep; 161(6):I-30. PubMed ID: 25222407
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
    O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY
    Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Better outcomes with generic statins.
    Harv Heart Lett; 2014 Dec; 25(4):8. PubMed ID: 26094262
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
    Gagne JJ; Choudhry NK; Kesselheim AS; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
    Ann Intern Med; 2014 Sep; 161(6):400-7. PubMed ID: 25222387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient co-payment and adherence to statins: a review and case studies.
    Simoens S; Sinnaeve PR
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):99-109. PubMed ID: 24150747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
    Wong MC; Wang HH; Liu KS
    Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
    [No Abstract]   [Full Text] [Related]  

  • 8. The case for generic statins: not if they don't work so well.
    Borzak S
    JAMA Intern Med; 2013 Aug; 173(15):1473-4. PubMed ID: 23939520
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of generic substitution on refill adherence to statin therapy: a nationwide population-based study.
    Trusell H; Sundell KA
    BMC Health Serv Res; 2014 Dec; 14():626. PubMed ID: 25475416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching statins.
    Moon JC; Bogle RG
    BMJ; 2006 Jun; 332(7554):1344-5. PubMed ID: 16763226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What you should know about: generic vs. brand-name statins.
    Harv Health Lett; 2013 Sep; 38(11):7. PubMed ID: 27024693
    [No Abstract]   [Full Text] [Related]  

  • 12. Compliance after switching from branded to generic statins.
    Romanelli RJ; Jukes T; Segal JB
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1093-100. PubMed ID: 24817435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching statins: NICE tool overestimates benefits of statins.
    Mackenzie DG
    BMJ; 2006 Jun; 332(7556):1512-3. PubMed ID: 16793830
    [No Abstract]   [Full Text] [Related]  

  • 14. Switching statins: how to do it without tears and to benefit the NHS.
    Lau T
    BMJ; 2006 Jun; 332(7556):1513. PubMed ID: 16793835
    [No Abstract]   [Full Text] [Related]  

  • 15. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL; Cox ER
    Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zero copayment for generic statins could save billions.
    Manag Care; 2013 Mar; 22(3):44. PubMed ID: 23610806
    [No Abstract]   [Full Text] [Related]  

  • 17. Does treatment with statins protect against psoriasis?
    Egeberg A; Riis Hansen P
    Br J Dermatol; 2015 Aug; 173(2):327-8. PubMed ID: 26346083
    [No Abstract]   [Full Text] [Related]  

  • 18. Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies.
    Kesselheim AS; Bykov K; Avorn J; Tong A; Doherty M; Choudhry NK
    Ann Intern Med; 2014 Jul; 161(2):96-103. PubMed ID: 25023248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices.
    Plans-Rubió P
    Am J Cardiovasc Drugs; 2010; 10(6):369-82. PubMed ID: 21090830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence--estimates from the Finnish prescription register.
    Aarnio E; Korhonen MJ; Huupponen R; Martikainen J
    Atherosclerosis; 2015 Mar; 239(1):240-7. PubMed ID: 25618032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.